Valuation: West Pharmaceutical Services, Inc.

Market Cap 24.39B 21.06B 19.76B 17.99B 33.83B 2,332B 34.3B 232B 90.75B 1,168B 91.58B 89.6B 3,887B P/E 2026 *
40.4x
P/E 2027 * 35.1x
Enterprise Value 23.89B 20.62B 19.35B 17.62B 33.14B 2,284B 33.6B 227B 88.88B 1,144B 89.69B 87.75B 3,807B EV / Sales 2026 *
7.08x
EV / Sales 2027 * 6.51x
Free-Float
92.89%
Yield 2026 *
0.26%
Yield 2027 * 0.28%
1 day-0.08%
1 week-2.24%
Current month+0.68%
1 month-4.70%
3 months+15.17%
6 months+45.08%
Current year+27.57%
1 week 296.1
Extreme 296.1
303.6
1 month 287.7
Extreme 287.7
340
Current year 191.35
Extreme 191.35
340
1 year 191.35
Extreme 191.35
340
3 years 168.95
Extreme 168.95
380.1
5 years 168.95
Extreme 168.95
420.2
10 years 63.15
Extreme 63.153
420.2
Manager TitleAgeSince
Chief Executive Officer 56 24/04/2015
Director of Finance/CFO 57 04/08/2025
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 65 01/02/2011
Director/Board Member 69 07/03/2011
Director/Board Member 56 12/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
-0.08%-2.24% - - 24.39B
-0.79%+1.61%-16.23%+5.18% 191B
-0.73%+1.33%-2.60%+11.08% 116B
-0.41%-3.84%+6.73%+73.62% 59.64B
-0.42%+1.08%+34.00%+70.00% 55.42B
-0.71%+1.37%-7.07%-33.92% 49.6B
-1.10%+1.27%+9.65%-17.67% 33.49B
-2.41%+3.16% - - 30.6B
-1.60%-0.79%-7.55%+24.99% 24.25B
-0.80%-1.57%+40.78%-11.77% 24.39B
Average -0.31%+0.63%+7.21%+15.19% 64.93B
Weighted average by Cap. +0.32%+0.81%-0.60%+15.51%

Financials

2026 *2027 *
Net sales 3.37B 2.91B 2.73B 2.49B 4.68B 323B 4.75B 32.04B 12.56B 162B 12.67B 12.4B 538B 3.59B 3.1B 2.91B 2.65B 4.98B 343B 5.04B 34.06B 13.35B 172B 13.47B 13.18B 572B
Net income 615M 531M 498M 453M 852M 58.76B 864M 5.83B 2.29B 29.44B 2.31B 2.26B 97.92B 701M 605M 568M 517M 973M 67.05B 986M 6.66B 2.61B 33.59B 2.63B 2.58B 112B
Net Debt -503M -434M -408M -371M -698M -48.12B -708M -4.78B -1.87B -24.11B -1.89B -1.85B -80.19B -1.04B -897M -842M -767M -1.44B -99.35B -1.46B -9.87B -3.87B -49.78B -3.9B -3.82B -166B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Date Price Change
18/08/26 296.10 -1.04%
17/08/26 €299.20 +0.50%
14/08/26 €297.70 -1.94%
13/08/26 €303.60 +0.33%
12/08/26 €302.60 -0.10%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
346.61USD
Average target price
404.73USD
Spread / Average Target
+16.77%

Quarterly revenue - Rate of surprise